New View Surgical is proud to be recognized as one of the Top 10 Companies to Watch in 2023 by Medtech Outlook Magazine
New View Surgical Announces First Commercial Case of the VisionPort™ System, Performed by David Earle, M.D., F.A.C.S.
New View Surgical, Inc. Closes $12.1M Series B-1 Financing, Readies Limited Market Release of its VisionPort™ System For Minimally Invasive Surgery
How to Find Product-Market Fit by Going Deep Versus Wide: Interview with New View Surgical CEO Bryce Klontz
New View Surgical, Inc. Strengthens Executive Leadership Team with Appointment of Shane Johnson as Chief Commercial Officer
New View Surgical, Inc. Closes $9M Series B Financing to Fund Initial Market Release of its VisionPort™ System for Minimally Invasive Surgery
In this episode, Giovanni and Bryce discuss raising capital from angel groups, the differences between angels and VCs, east vs. west coast investors and more.
New View Surgical, Inc. Announces FDA Clearance of its VisionPort™ System for Minimally Invasive Surgery
New View Surgical, Inc. Recognized as ‘Most Valued Company’ at virtual Keiretsu Forum Investor Capital Expo
New View Surgical, Inc. Closes Series A Round of Financing
Mid Atlantic Bio Angels Invests in New View Surgical